Has experience in Immunology, focusing on Celular Imunology (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by the severe acute respiratory syndrome coronavirus - 2 (SARS-CoV-2). Approximately 80% of patients with COVID-19 have mild to moderate symptoms, 13.8% have severe disease (dyspnea, tachypnea, and hypoxia) and 6.1% develop critical symptoms (respiratory failure, septic shock or multiple organ dysfunction). The l…
An Antiphospholipid Antibody syndrome (APS) is an autoimmune disease which has as main characteristic the recurrence of idiopathic thrombotic events associated with the presence of anti-phospholipid antibodies (aPL). It is estimated that affects 2-4% of the world population; Being thus associated with 20% of cases of deep venous thrombosis, gestational loss and stroke ischemic stroke (CVA…
Guillain-Barré syndrome (GBS) is an acute inflammatory disease of the peripheral nervous system, with considerable mortality. The experimental autoimmune neuritis (EAN)is the experimental model of the GBS, which culminates in the demyelination of the peripheral nerves. This response is mediated by Th1 / Th17 speacially. Despite, it is still to be elucidated how T cells would be capable to…
Peripheral artery disease (PAD) is characterized by numbness, swelling, and pain of the extremities that occurs after brief periods of walking or exercise. Approximately 2% of patients afflicted with PAD will experience worsening symptoms and develop Critical Limb Ischemia (CLI), characterized by its intense claudication and high risk for amputation and cardiovascular complications. Withi…
| 3 / 3 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 4 / 4 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID